Connection

DAVID BATES to Drug-Related Side Effects and Adverse Reactions

This is a "connection" page, showing publications DAVID BATES has written about Drug-Related Side Effects and Adverse Reactions.
  1. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events. Drug Saf. 2021 05; 44(5):601-607.
    View in: PubMed
    Score: 0.606
  2. Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care Unit. Drug Saf. 2019 04; 42(4):573-579.
    View in: PubMed
    Score: 0.531
  3. The national cost of adverse drug events resulting from inappropriate medication-related alert overrides in the United States. J Am Med Inform Assoc. 2018 09 01; 25(9):1183-1188.
    View in: PubMed
    Score: 0.510
  4. Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit. BMJ Qual Saf. 2018 09; 27(9):718-724.
    View in: PubMed
    Score: 0.491
  5. Evaluation of medication-related clinical decision support alert overrides in the intensive care unit. J Crit Care. 2017 06; 39:156-161.
    View in: PubMed
    Score: 0.459
  6. Evaluation of Perioperative Medication Errors and Adverse Drug Events. Anesthesiology. 2016 Jan; 124(1):25-34.
    View in: PubMed
    Score: 0.424
  7. To err is human: lessons from patient safety research for transplant care. Clin J Am Soc Nephrol. 2014 May; 9(5):845-7.
    View in: PubMed
    Score: 0.377
  8. Impact of vendor computerized physician order entry on patients with renal impairment in community hospitals. J Hosp Med. 2013 Oct; 8(10):545-52.
    View in: PubMed
    Score: 0.363
  9. Return on investment for vendor computerized physician order entry in four community hospitals: the importance of decision support. Jt Comm J Qual Patient Saf. 2013 Jul; 39(7):312-8.
    View in: PubMed
    Score: 0.356
  10. Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool. J Am Med Inform Assoc. 2013 Jun; 20(e1):e85-90.
    View in: PubMed
    Score: 0.352
  11. Overrides of clinical decision support alerts in primary care clinics. Stud Health Technol Inform. 2013; 192:923.
    View in: PubMed
    Score: 0.344
  12. Understanding responses to a renal dosing decision support system in primary care. Stud Health Technol Inform. 2013; 192:931.
    View in: PubMed
    Score: 0.344
  13. Active pharmacovigilance and healthcare utilization. Am J Manag Care. 2012 11 01; 18(11):e423-8.
    View in: PubMed
    Score: 0.340
  14. The costs of adverse drug events in community hospitals. Jt Comm J Qual Patient Saf. 2012 Mar; 38(3):120-6.
    View in: PubMed
    Score: 0.325
  15. Impact of vendor computerized physician order entry in community hospitals. J Gen Intern Med. 2012 Jul; 27(7):801-7.
    View in: PubMed
    Score: 0.323
  16. Outpatient adverse drug events identified by screening electronic health records. J Patient Saf. 2010 Jun; 6(2):91-6.
    View in: PubMed
    Score: 0.288
  17. Adverse drug event rates in six community hospitals and the potential impact of computerized physician order entry for prevention. J Gen Intern Med. 2010 Jan; 25(1):31-8.
    View in: PubMed
    Score: 0.277
  18. Measuring patient safety: the need for prospective detection of adverse events. Stud Health Technol Inform. 2009; 148:3.
    View in: PubMed
    Score: 0.261
  19. Adverse drug events in pediatric outpatients. Ambul Pediatr. 2007 Sep-Oct; 7(5):383-9.
    View in: PubMed
    Score: 0.238
  20. Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf. 2007 Sep; 2(3):177-85.
    View in: PubMed
    Score: 0.238
  21. Medication safety in a psychiatric hospital. Gen Hosp Psychiatry. 2007 Mar-Apr; 29(2):156-62.
    View in: PubMed
    Score: 0.230
  22. Pediatric medication safety and the media: what does the public see? Pediatrics. 2006 Jun; 117(6):1907-14.
    View in: PubMed
    Score: 0.218
  23. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006 Mar 13; 166(5):565-71.
    View in: PubMed
    Score: 0.215
  24. Adherence to black box warnings for prescription medications in outpatients. Arch Intern Med. 2006 Feb 13; 166(3):338-44.
    View in: PubMed
    Score: 0.214
  25. Patient-reported medication symptoms in primary care. Arch Intern Med. 2005 Jan 24; 165(2):234-40.
    View in: PubMed
    Score: 0.199
  26. Adverse Drug Events in Ambulatory Care: A Cross-Sectional Study. Drug Saf. 2025 Apr; 48(4):363-374.
    View in: PubMed
    Score: 0.197
  27. Strategies for detecting adverse drug events among older persons in the ambulatory setting. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):492-8.
    View in: PubMed
    Score: 0.192
  28. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004 Aug; 13(4):306-14.
    View in: PubMed
    Score: 0.192
  29. Adverse drug events in ambulatory care. N Engl J Med. 2003 Apr 17; 348(16):1556-64.
    View in: PubMed
    Score: 0.176
  30. Electronically screening discharge summaries for adverse medical events. J Am Med Inform Assoc. 2003 Jul-Aug; 10(4):339-50.
    View in: PubMed
    Score: 0.175
  31. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003 Mar 05; 289(9):1107-16.
    View in: PubMed
    Score: 0.174
  32. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med. 2003 Feb 04; 138(3):161-7.
    View in: PubMed
    Score: 0.173
  33. The Safety of Inpatient Health Care. N Engl J Med. 2023 01 12; 388(2):142-153.
    View in: PubMed
    Score: 0.173
  34. Heterogeneity of Drug Allergies and Reaction Lists in Two U.S. Health Care Systems' Electronic Health Records. Appl Clin Inform. 2022 05; 13(3):741-751.
    View in: PubMed
    Score: 0.165
  35. Intelligent Telehealth in Pharmacovigilance: A Future Perspective. Drug Saf. 2022 05; 45(5):449-458.
    View in: PubMed
    Score: 0.165
  36. Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review. Lancet Digit Health. 2022 02; 4(2):e137-e148.
    View in: PubMed
    Score: 0.159
  37. Renal medication-related clinical decision support (CDS) alerts and overrides in the inpatient setting following implementation of a commercial electronic health record: implications for designing more effective alerts. J Am Med Inform Assoc. 2021 06 12; 28(6):1081-1087.
    View in: PubMed
    Score: 0.155
  38. Costs of drug-related morbidity and mortality: enormous and growing rapidly. J Am Pharm Assoc (Wash). 2001 Mar-Apr; 41(2):156-7.
    View in: PubMed
    Score: 0.152
  39. Preventable medication errors: identifying and eliminating serious drug interactions. J Am Pharm Assoc (Wash). 2001 Mar-Apr; 41(2):159-60.
    View in: PubMed
    Score: 0.152
  40. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf. 2001 Mar-Apr; 10(2):113-9.
    View in: PubMed
    Score: 0.152
  41. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000 Aug 01; 109(2):87-94.
    View in: PubMed
    Score: 0.146
  42. Identifying drug safety issues: from research to practice. Int J Qual Health Care. 2000 Feb; 12(1):69-76.
    View in: PubMed
    Score: 0.141
  43. Medication errors and adverse drug events in a UK hospital during the optimisation of electronic prescriptions: a prospective observational study. Lancet Digit Health. 2019 12; 1(8):e403-e412.
    View in: PubMed
    Score: 0.138
  44. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999 Jul 21; 282(3):267-70.
    View in: PubMed
    Score: 0.136
  45. Frequency, consequences and prevention of adverse drug events. J Qual Clin Pract. 1999 Mar; 19(1):13-7.
    View in: PubMed
    Score: 0.132
  46. Screening for Adverse Drug Events: a Randomized Trial of Automated Calls Coupled with Phone-Based Pharmacist Counseling. J Gen Intern Med. 2019 02; 34(2):285-292.
    View in: PubMed
    Score: 0.128
  47. A value set for documenting adverse reactions in electronic health records. J Am Med Inform Assoc. 2018 06 01; 25(6):661-669.
    View in: PubMed
    Score: 0.125
  48. Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record. J Gen Intern Med. 2018 11; 33(11):1868-1876.
    View in: PubMed
    Score: 0.125
  49. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997 Jan 22-29; 277(4):307-11.
    View in: PubMed
    Score: 0.114
  50. Ambulatory Computerized Prescribing and Preventable Adverse Drug Events. J Patient Saf. 2016 06; 12(2):69-74.
    View in: PubMed
    Score: 0.109
  51. Pharmacosurveillance without borders: electronic health records in different countries can be used to address important methodological issues in estimating the risk of adverse events. J Clin Epidemiol. 2016 09; 77:101-111.
    View in: PubMed
    Score: 0.109
  52. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995 Jul 05; 274(1):29-34.
    View in: PubMed
    Score: 0.102
  53. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995 Apr; 10(4):199-205.
    View in: PubMed
    Score: 0.101
  54. Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study. BMJ Qual Saf. 2014 Oct; 23(10):830-7.
    View in: PubMed
    Score: 0.094
  55. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993 Jun; 8(6):289-94.
    View in: PubMed
    Score: 0.089
  56. Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1221-6.
    View in: PubMed
    Score: 0.084
  57. Preventable adverse drug events and their causes and contributing factors: the analysis of register data. Int J Qual Health Care. 2011 Apr; 23(2):187-97.
    View in: PubMed
    Score: 0.075
  58. Impact of implementing alerts about medication black-box warnings in electronic health records. Pharmacoepidemiol Drug Saf. 2011 Feb; 20(2):192-202.
    View in: PubMed
    Score: 0.075
  59. Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification. World J Biol Psychiatry. 2008; 9(1):24-33.
    View in: PubMed
    Score: 0.061
  60. Medication dispensing errors and potential adverse drug events before and after implementing bar code technology in the pharmacy. Ann Intern Med. 2006 Sep 19; 145(6):426-34.
    View in: PubMed
    Score: 0.056
  61. The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005 Aug; 33(8):1694-700.
    View in: PubMed
    Score: 0.051
  62. Multifaceted approach to reducing preventable adverse drug events. Am J Health Syst Pharm. 2003 Mar 15; 60(6):582-6.
    View in: PubMed
    Score: 0.044
  63. Detecting adverse events using information technology. J Am Med Inform Assoc. 2003 Mar-Apr; 10(2):115-28.
    View in: PubMed
    Score: 0.044
  64. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc. 1999 Jul-Aug; 6(4):313-21.
    View in: PubMed
    Score: 0.034
  65. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998 Oct 21; 280(15):1311-6.
    View in: PubMed
    Score: 0.032
  66. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997 Aug; 25(8):1289-97.
    View in: PubMed
    Score: 0.030
  67. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995 Jul 05; 274(1):35-43.
    View in: PubMed
    Score: 0.026
  68. A safe practice standard for barcode technology. J Patient Saf. 2015 Jun; 11(2):89-99.
    View in: PubMed
    Score: 0.025
  69. Using electronic health record clinical decision support is associated with improved quality of care. Am J Manag Care. 2014 Oct 01; 20(10):e445-52.
    View in: PubMed
    Score: 0.024
  70. Potential identifiability and preventability of adverse events using information systems. J Am Med Inform Assoc. 1994 Sep-Oct; 1(5):404-11.
    View in: PubMed
    Score: 0.024
  71. Effect of bar-code technology on the safety of medication administration. N Engl J Med. 2010 May 06; 362(18):1698-707.
    View in: PubMed
    Score: 0.018
  72. A randomized trial of electronic clinical reminders to improve medication laboratory monitoring. J Am Med Inform Assoc. 2008 Jul-Aug; 15(4):424-9.
    View in: PubMed
    Score: 0.016
  73. Computerized physician order entry with clinical decision support in the long-term care setting: insights from the Baycrest Centre for Geriatric Care. J Am Geriatr Soc. 2005 Oct; 53(10):1780-9.
    View in: PubMed
    Score: 0.013
  74. Effect of bar-code technology on the incidence of medication dispensing errors and potential adverse drug events in a hospital pharmacy. AMIA Annu Symp Proc. 2005; 1085.
    View in: PubMed
    Score: 0.012
  75. Characteristics and consequences of drug allergy alert overrides in a computerized physician order entry system. J Am Med Inform Assoc. 2004 Nov-Dec; 11(6):482-91.
    View in: PubMed
    Score: 0.012
  76. The incident reporting system does not detect adverse drug events: a problem for quality improvement. Jt Comm J Qual Improv. 1995 Oct; 21(10):541-8.
    View in: PubMed
    Score: 0.007
  77. A new knowledge structure for drug-drug interactions. Proc Annu Symp Comput Appl Med Care. 1994; 836-40.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.